This is true and we all know insurance companies like to save money wherever they can but let's get real - SI claimed in January that there had been 'more than half a dozen' enquiries for Ryoncil. These patients don't have time to wait around for 'red tape' so what happened with them ?
Did Mesoblast provide Ryoncil at a discount or for free for these patients ? Why did yesterday's update not include the number of patients treated to date .... sadly the market has interpreted the non disclosure in this regard as zero patients treated almost 3 months out from FDA approval and IMO the shorts are going to continue what they started a month ago ? They are in a pickle if anything out of left field lands but for the time being I think they will safely cover what they have shorted all the way down from the highs of almost $1 above yesterday's close
@Lopez only posts the 'positive' posts from Ecool over yonder so it's no wonder he hasn't posted anything from him of late as Ecool is also keeping it 'real' as he constantly complains about the current CEO. He has a point and so does @Pledge regardless of the pushback towards him on here .... time for change me thinks
MSB Price at posting:
$2.53 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)